iShares Biotechnology ETF
843 hedge funds and large institutions have $7.66B invested in iShares Biotechnology ETF in 2021 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 293 increasing their positions, 269 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $8.89B → $7.66B (-$1.23B)
47% less funds holding in top 10
Funds holding in top 10: 15 → 8 (-7)
60% less call options, than puts
Call options by funds: $329M | Put options by funds: $825M
Holders
843
Holding in Top 10
8
Calls
$329M
Puts
$825M
Top Buyers
| 1 | +$242M | |
| 2 | +$234M | |
| 3 | +$66.8M | |
| 4 |
CI Investments Inc
Toronto,
Ontario, Canada
|
+$61.6M |
| 5 |
Millennium Management
New York
|
+$35.8M |
Top Sellers
| 1 | -$463M | |
| 2 | -$442M | |
| 3 | -$335M | |
| 4 |
CM
Churchill Management
Los Angeles,
California
|
-$181M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$159M |